1. Bai, JW, Boulet, G, Halpern, EM, et al. Cardiovascular disease guideline adherence and self-reported statin use in longstanding type 1 diabetes: results from the Canadian study of longevity in diabetes cohort. Cardiovasc Diabetol. 2016;15:14. https://doi-org.proxyse.uits.iu.edu/10.1186/s12933-015-0318-9
Google Scholar2. Chou, R, Dana, T, Blazina, I, Daeges, M, Jeanne, TL. Statins for prevention of cardiovascular disease in adults: evidence report and systematic review for the US preventive services task force. JAMA. 2016;316(19):2008–2024. https://doi-org.proxyse.uits.iu.edu/10.1001/jama.2015.15629
Google Scholar3. Bitzur, R . Remembering statins: do statins have adverse cognitive effects? Diabetes Care. 2016;39(suppl 2):S253–S259. https://doi-org.proxyse.uits.iu.edu/10.2337/dcS15-3022
Google Scholar | Crossref | Medline4. Chu, CS, Tseng, PT, Stubbs, B, et al. Use of statins and the risk of dementia and mild cognitive impairment: a systematic review and meta-analysis. Sci Rep. 2018;8(1):5804.
Google Scholar | Crossref5. Ott, BR, Daiello, LA, Dahabreh, IJ, et al. Do statins impair cognition? A systematic review and meta-analysis of randomized controlled trials. J Gen Intern Med. 2015;30(3):348–358.
Google Scholar | Crossref | Medline6. Swiger, KJ, Manalac, RJ, Blumenthal, RS, Blaha, MJ, Martin, SS. Statins and cognition: a systematic review and meta-analysis of short-and long-term cognitive effects. Mayo Clin Proc. 2013;88(11):1213–1221.
Google Scholar | Crossref | Medline | ISI7. Zambón, D, Quintana, M, Mata, P, et al. Higher incidence of mild cognitive impairment in familial hypercholesterolemia. Am J Med. 2010;123(3):267–274.
Google Scholar | Crossref | Medline8. Li, G, Larson, EB, Sonnen, JA, et al. Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease. Neurology. 2007;69(9):878–885.
Google Scholar | Crossref | Medline9. Tan, B, Rosenfeldt, F, Ou, R, Stough, C. Evidence and mechanisms for statin-induced cognitive decline. Exp Rev Clin Pharmacol. 2019:1–10. https://doi-org.proxyse.uits.iu.edu/10.1080/17512433.2019.1606711
Google Scholar10. Lezak, M, Howieson, D, Bigler, E, Tranel, D. Neuropsychological Assessment—Fifth Edition. New York, NY: Oxford University Press; 2012.
Google Scholar11. Miron, VE, Rajasekharan, S, Jarjour, AA, Zamvil, SS, Kennedy, TE, Antel, JP. Simvastatin regulates oligodendroglial process dynamics and survival. Glia. 2007;55(2):130–143.
Google Scholar | Crossref | Medline12. Yousef, AO, Fahad, A, Abdel Moneim, AE, Metwally, DM, El-Khadragy, MF, Kassab, RB. The neuroprotective role of coenzyme Q10 against lead acetate-induced neurotoxicity is mediated by antioxidant, anti-inflammatory and anti-apoptotic activities. Int J Environ Res Public Health. 2019;16(16):2895. https://doi-org.proxyse.uits.iu.edu/10.3390/ijerph16162895
Google Scholar13. Dumont, M, Kipiani, K, Yu, F, et al. Coenzyme Q10 decreases amyloid pathology and improves behavior in a transgenic mouse model of Alzheimer’s disease. J Alzheimer’s Dis. 2011;27(1):211–223.
Google Scholar | Crossref | Medline | ISI14. Hernández-Camacho, JD, Bernier, M, López-Lluch, G, Navas, P. Coenzyme Q10 supplementation in aging and disease. Front Physiol. 2018;9:44. doi:10.3389/fphys.2018.00044
Google Scholar | Crossref | Medline15. Wojsiat, J, Zoltowska, K, Laskowska-Kaszub, K, Wojda, U. Oxidant/antioxidant imbalance in Alzheimer’s disease: therapeutic and diagnostic prospects. Oxid Med Cell Longev. 2018;2018:6435861.
Google Scholar | Crossref | Medline16. Stough, C, Nankivell, M, Camfield, DA, et al. CoQ10 and cognition a review and study protocol for a 90-day randomized controlled trial investigating the cognitive effects of ubiquinol in the healthy elderly. Front Aging Neurosci. 2019;11:103.
Google Scholar | Crossref | Medline17. Johnson, SC, Koscik, RL, Jonaitis, EM, et al. The Wisconsin Registry for Alzheimer’s prevention: a review of findings and current directions. Alzheimers Dement (Amst). 2017:10:130–142. doi:10.1101/206839
Google Scholar | Crossref | Medline18. Aging Brain Care . Anticholinergic Burden Scale; 2012. Accessed January 24, 2020. http://www.idhca.org/wp-content/uploads/2018/02/DESAI_ACB_scale_-_Legal_size_paper.pdf.
Google Scholar19. Radloff, LS . The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1(3):385–401.
Google Scholar | SAGE Journals20. Wechsler, D . Wechsler Abbreviated Scale of Intelligence. New York, NY: The Psychological Corporation: Harcourt Brace & Company; 1997.
Google Scholar21. Folstein, MF, Folstein, SE, McHugh PR . “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–198.
Google Scholar | Crossref | Medline | ISI22. Wechsler, D . Wechsler Adult Intelligence Scale—Revised. New York, NY: Harcourt Brace & CO. for the Psychological Corporation; 1981.
Google Scholar23. Schmidt, M . Rey Auditory Verbal Learning Test: A Handbook. Los Angeles, CA: Western Psychological Services; 1996.
Google Scholar24. Reitan, RM . Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills. 1958;8(3):271–276.
Google Scholar | SAGE Journals25. Wechsler, D . Wechsler Memory Scale—Revised. New York, NY: Harcourt Brace Jovanovich, Inc. for the Psychological Corporation; 1987.
Google Scholar26. IBM . SPSS Statistics Version 26. Armonk, NY: IBM Corp; 2019.
Google Scholar27. Benjamini, Y, Yekutieli, D. False discovery rate–adjusted multiple confidence intervals for selected parameters. J Am Stat Assoc. 2005;100(469):71–81.
Google Scholar | Crossref28. Cordero, MD, Cotán, D, del-Pozo-Martín, Y, et al. Oral coenzyme Q10 supplementation improves clinical symptoms and recovers pathologic alterations in blood mononuclear cells in a fibromyalgia patient. Nutrition. 2012;28(11-12):1200–1203.
Google Scholar | Crossref | Medline29. Nachvak, SM, Alipour, B, Mahdavi, AM, et al. Effects of coenzyme Q10 supplementation on matrix metalloproteinases and DAS-28 in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled clinical trial. Clin Rheumatol. 2019;38(12):3367–3374.
Google Scholar | Crossref | Medline30. Abad, FJ, Sorrel, MA, Román, FJ, Colom, R. The relationships between WAIS-IV factor index scores and educational level: a bifactor model approach. Psychol Assess. 2016;28(8):987–1000. https://doi-org.proxyse.uits.iu.edu/10.1037/pas0000228
Google Scholar31. Nishita, Y, Tange, C, Tomida, M, Ando, F, Shimokata, H. Does high educational level protect against intellectual decline in older adults?; A 10-year longitudinal study. Jpn Psychol Res. 2013;55(4):378–389. doi:10.1111/jpr.12028
Google Scholar | Crossref32. Wilson, RS, Hebert, LE, Scherr, PA, Barnes, LL, Mendes de Leon, CF, Evans, DA. Educational attainment and cognitive decline in old age. Neurology. 2009;72(5):460–465.
Google Scholar | Crossref | Medline | ISI